![Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/cta_tabletemp_tables415_348489.jpg)
Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor
![Implementation of an antimicrobial stewardship program for patients with febrile neutropenia - American Journal of Infection Control Implementation of an antimicrobial stewardship program for patients with febrile neutropenia - American Journal of Infection Control](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cf3855c5-561c-4241-b341-1fd9a684c957/ymic4622-fig-0001_lrg.jpg)
Implementation of an antimicrobial stewardship program for patients with febrile neutropenia - American Journal of Infection Control
![Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/cta_tabletemp_tables216_348481.jpg)
Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor
![The role of temperature in the detection and diagnosis of neutropenic sepsis in adult solid tumour cancer patients receiving chemotherapy - ScienceDirect The role of temperature in the detection and diagnosis of neutropenic sepsis in adult solid tumour cancer patients receiving chemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1462388918301108-gr1.jpg)
The role of temperature in the detection and diagnosis of neutropenic sepsis in adult solid tumour cancer patients receiving chemotherapy - ScienceDirect
![Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO) Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-019-03622-0/MediaObjects/277_2019_3622_Fig1_HTML.png)
Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)
![Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial - The Lancet Haematology Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial - The Lancet Haematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2117307798/2085450157/gr1.gif)
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial - The Lancet Haematology
![PDF] Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. | Semantic Scholar PDF] Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5e9044f88731946ae8c9c465dbd885eb26a9de9a/6-Table2-1.png)
PDF] Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. | Semantic Scholar
![Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study - eClinicalMedicine Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d4ee8b91-9f01-4df4-8472-74f51220f571/gr1_lrg.jpg)
Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study - eClinicalMedicine
![Impact of a qualitative intervention with a unique febrile neutropenia management protocol in haematological patients in a tertiary centre - MedCrave online Impact of a qualitative intervention with a unique febrile neutropenia management protocol in haematological patients in a tertiary centre - MedCrave online](https://medcraveonline.com/HTIJ/images/HTIJ-04-00090-g001.png)